In this review:
Overlapping genetic architecture between Parkinson’s disease and melanoma
SUMMIST will assess the efficacy of metastasectomy following PD-1 inhibition for metastatic melanoma
ddPCR allows monitoring of KRAS mutational accrual in patients with congenital melanocytic naevi
Germline genetic variants influence on dermoscopic features of melanoma
Molecular mechanisms of resistance to immunotherapy in human melanoma
Lung cancer screening is warranted in familial melanoma CDKN2A mutation carriers
Melanoma in children and adolescents
Development of a new molecular predictor for risk of melanoma brain metastases
Midkine promotes immune dysregulation and resistance to immunotherapy
Midkine inhibits dormancy of melanoma disseminated tumour cells
Please login below to download this issue (PDF)